Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Atrial fibrillation–induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction
Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan
Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan
View: Text | PDF
Research Article Cardiology Vascular biology

Atrial fibrillation–induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction

  • Text
  • PDF
Abstract

Atrial fibrillation (AF) is a prevalent arrhythmia with known detriments such as heart failure, stroke, and cognitive decline even in patients without prior stroke. The mechanisms by which AF leads to cognitive dysfunction are yet unknown, and there is a lack of animal models to study this disease process. We previously developed a murine model of spontaneous and prolonged episodes of AF, a double transgenic mouse model with cardiac-specific expression of a gain-of-function mutant voltage-gated sodium channel (DTG-AF mice). Herein, we show, for the first time to our knowledge, a murine model of AF without any cerebral infarcts exhibiting cognitive dysfunction, including impaired visual learning and cognitive flexibility on touch screen testing. Mesenteric resistance arterial function of DTG-AF mice showed significant loss of myogenic tone, increased wall thickness and distensibility, and mitochondrial dysfunction. Brain pial arteries also showed increased wall thickness and mitochondrial enlargement. Furthermore, DTG-AF mice have decreased brain perfusion on laser speckle contrast imaging compared with controls. Cumulatively, these findings demonstrate that AF leads to vascular structural and functional alterations necessary for dynamic cerebral autoregulation, resulting in increased cerebral stress and cognitive dysfunction. Expression of mitochondrial catalase (mCAT) to reduce mitochondrial reactive oxygen species (ROS) was sufficient to prevent vascular dysfunction due to AF, restore perfusion, and improve cognitive flexibility.

Authors

Pavithran Guttipatti, Ruiping Ji, Najla Saadallah, Uma Mahesh R. Avula, Deniz Z. Sonmez, Albert Fang, Eric Li, Amar D. Desai, Samantha Parsons, Parmanand Dasrat, Christine Sison, Yanping Sun, Chris N. Goulbourne, Steven R. Reiken, Elaine Y. Wan

×

Figure 5

Loss of myogenic tone and increased arterial wall thickness in DTG-AF mice correctable with mCAT.

Options: View larger image (or click on image) Download as PowerPoint
Loss of myogenic tone and increased arterial wall thickness in DTG-AF mi...
(A) Myogenic tone of third-order mesenteric arteries measured ex vivo as fraction of active diameter to maximal passive diameter in the absence of Ca2+, at each intraluminal pressure. Control mice demonstrate typical myogenic response of increased constriction with increased intraluminal pressure. DTG-AF mice have significantly reduced constriction at 80 mmHg and 120 mmHg, which is prevented in mCAT-DTG-AF mice. Two-way repeated-measures ANOVA with Tukey’s multiple-comparison test: 80 mmHg control versus DTG-AF P < 0.001, DTG-AF versus mCAT-DTG-AF P < 0.001, mCAT-DTG-AF versus control P = NS, 120 mm Hg control versus DTG-AF P < 0.001, DTG-AF versus mCAT-DTG-AF P < 0.001, mCAT-DTG-AF versus control P = NS (n = 9 control, n = 9 DTG-AF, n = 9 mCAT-DTG-AF mesenteric arteries). (B) Wall thickness of mesenteric arteries at increasing intraluminal pressures. DTG-AF vessels are significantly thicker than control vessels, particularly at low and high ends of pressure, and mCAT coexpression normalizes wall thickness. Two-way repeated-measures ANOVA with Tukey’s multiple-comparison test, all significant comparisons denoted with *P < 0.05 (n = 3 control, n = 3 DTG-AF, n = 3 mCAT-DTG-AF vessels). (C) Distensibility studies via measuring vessel diameter under varying pressures in Ca2+ free solution reveals significantly differing effect of pressure on distensibility in DTG-AF mice. Generalized estimating equations (P < 0.05) (n = 4 control and n = 7 DTG-AF vessels). Data are shown as mean ± SEM, *P < 0.05, ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts